EJ Emanuel, Y Young-Xu, NG Levinsky, G … - Annals of internal medicine, 2003 - Am Coll Physicians Background: Although many observers believe that cancer chemotherapy is overused
at the end of life, there are no published data on this. ... Objective: To
determine the frequency and duration of chemotherapy use in the last 6 ... Cited by 123 - Related articles - All 7 versions
O Belvedere, F Grossi - Journal of Clinical Oncology, 2005 - jcojournal.org The randomized phase II study by Baka et al compared two schedules of
single-agent gemcitabine in patients with advanced non–small-cell lung cancer
(NSCLC) and impaired Karnofsky performance status (KPS 70%). 1 One hundred ... Cited by 53 - Related articles - All 5 versions
DY Oh, JE Kim, CH Lee, JS Lim, KH Jung, DS … - CA A Cancer Journal for Clinicians - interscience.wiley.com One hundred fourteen patients with either advanced-stage or terminal disease
were enrolled in the current study. Questionnaires were administered to the duty
physician and to patients' family members. The questions covered issues ... Cited by 73 - Related articles - BL Direct - All 5 versions
- ►ascopubs.org M Agrawal, C Grady, DL Fairclough, NJ … - Journal of Clinical Oncology, 2006 - jco.ascopubs.org RESULTS: Of the 163 participants, 88% were white, 96% had health insurance, and
51% were college graduates or post graduates. Overall, 81% were aware of
hospice, but only 6% had seriously considered hospice for themselves; 84% ... Cited by 76 - Related articles - All 7 versions
- ►queensu.ca [PDF] MD Brundage, D Feldman-Stewart, R Cosby, R … - Patient Education and Counseling, 2001 - Elsevier The purpose of this study was to determine how people weigh both median survival
time and 1-year survival probability when considering a choice between
palliative Cisplatin-based chemotherapy with best supportive care (C+BSC) ... Cited by 87 - Related articles - All 8 versions
- ►pubget.com [PDF] D Sources, IC Use - Annals of Internal Medicine, 2003 - Am Coll Physicians Chemotherapy Use among Medicare Beneficiaries at the End of Life ... Ezekiel J.
Emanuel, MD, PhD; Yinong Young-Xu, MA; Norman G. Levinsky, MD; Gail Gazelle, MD;
Olga Saynina, MA; and Arlene S. Ash, PhD ... Background: Although many ... Related articles - All 2 versions
- ►ascopubs.org CC Earle, BA Neville, MB Landrum, JZ … - Journal of Clinical Oncology, 2004 - jco.ascopubs.org Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg
Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this? ...
Address reprint requests to Craig C. Earle, MD, MSc, Center for Outcomes ... Cited by 167 - Related articles - BL Direct - All 7 versions
JF Gonçalves, C Goyanes - Supportive Care in Cancer, 2008 - Springer Abstract Goals of work Chemotherapy plays a major role in the treatment of
cancer. However, it is sometimes thought of as being taken too far, being used
in many cases close to death. The purpose of this study is to determine the ... Cited by 2 - Related articles - BL Direct - All 3 versions
PB Bach, D Schrag, CB Begg - JAMA, 2004 - Am Med Assoc In this article we address whether studies of care rendered to patients prior to
their death ("studies of decedents") produce an accurate portrait of care
provided to patients who are dying. Studies of decedents typically analyze ... Cited by 43 - Related articles - BL Direct - All 4 versions
- ►ascopubs.org R Matsuyama, S Reddy, TJ Smith - Journal of Clinical Oncology, 2006 - jco.ascopubs.org RESULTS: Available patient sources provide little information about prognosis,
choices, alternatives, consequences, or how to choose. Many patients would
choose chemotherapy for a small benefit in health outcomes, and for a ... Cited by 46 - Related articles - All 7 versions
